Pretransplant plasma brain natriuretic peptide and N-terminal probrain natriuretic peptide are more useful prognostic markers of overall survival after allogeneic hematopoietic cell transplantation than echocardiography

被引：0
|
作者：
Naonori Harada
Hiroshi Okamura
Takahiko Nakane
Shiro Koh
Satoru Nanno
Mitsutaka Nishimoto
Asao Hirose
Mika Nakamae
Yasuhiro Nakashima
Hideo Koh
Masayuki Hino
Hirohisa Nakamae
机构：
[1] Osaka City University,Hematology, Graduate School of Medicine
来源：
Bone Marrow Transplantation | 2021年 / 56卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1467 / 1470
页数：3
相关论文
共 50 条
  • [11] Characterisation of N-terminal probrain natriuretic peptide in dialysis patients and its reduced prognostic significance in the elderly
    Sato, Yuji
    Ishizaki, Yuri
    Aso, Kumiko
    Minakwa, Akihiro
    Toida, Tatsunori
    Nishizono, Ryuzoh
    Kikuchi, Masao
    Inagaki, Hiroko
    Fujimoto, Shouichi
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [12] Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction - Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide
    Omland, T
    Aakvaag, A
    Bonarjee, VVS
    Caidahl, K
    Lie, RT
    Nilsen, DWT
    Sundsfjord, JA
    Dickstein, K
    CIRCULATION, 1996, 93 (11) : 1963 - 1969
  • [13] Drotrecogin alfa (activated) reduces the plasma levels of N-terminal prohormone atrial natriuretic peptide and N-terminal prohormone brain natriuretic peptide as markers of cardiac depression in septic patients
    U Hoffmann
    M Brückmann
    C Liebetrau
    S Lang
    T Bertsch
    M Borggrefe
    C Putensen
    S Schröder
    K Haase
    Critical Care, 8 (Suppl 1):
  • [14] N-terminal pro brain natriuretic peptide as a prognostic marker in the general population
    Groenning, BA
    Raymond, I
    Hildebrandt, PR
    Nilsson, JC
    Baumann, M
    Trawinski, J
    Pedersen, F
    EUROPEAN HEART JOURNAL, 2002, 23 : 571 - 571
  • [15] Effect of coronary artery stenosis on the plasma atrial natriuretic peptide, N-terminal proatrial natriuretic peptide, and brain natriuretic peptide in patients with coronary artery disease
    Ishimura, K
    Nishikimi, I
    Mori, Y
    Nakano, S
    Yoshida, K
    Yabe, A
    Horinaka, S
    Matuoka, H
    EUROPEAN HEART JOURNAL, 2004, 25 : 211 - 211
  • [16] Analytical correlation between plasma N-terminal pro-brain natriuretic peptide and brain natriuretic peptide in patients presenting with dyspnea
    Alibay, Y
    Beauchet, A
    El Mahmoud, R
    Brun-Ney, D
    Alexandre, JA
    Benoit, MO
    Dubourg, O
    Aegerter, P
    Boileau, C
    Jondeau, G
    Puy, H
    CLINICAL BIOCHEMISTRY, 2004, 37 (10) : 933 - 936
  • [17] Plasma brain natriuretic peptide and N-terminal proatrial natriuretic peptide levels in obese patients: A cause or result of hypertension? Response
    Wang, TJ
    Larson, MG
    Levy, D
    Benjamin, EJ
    Leip, EP
    Wilson, PWF
    Vasan, RS
    CIRCULATION, 2004, 110 (07) : E76 - E76
  • [18] Prognostic value of plasma N-terminal pro-brain natriuretic peptide in patients with severe sepsis
    Brueckmann, M
    Huhle, G
    Lang, S
    Haase, KK
    Bertsch, T
    Weiss, C
    Kaden, JJ
    Putensen, C
    Borggrefe, M
    Hoffmann, U
    CIRCULATION, 2005, 112 (04) : 527 - 534
  • [19] Is N-terminal probrain-type natriuretic peptide a clinically useful biomarker of volume overload in peritoneal dialysis patients?
    Papakrivopoulou, Eugenia
    Lillywhite, Samuel
    Davenport, Andrew
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (01) : 396 - 401
  • [20] Direct comparison between endothelin-1, N-terminal proatrial natriuretic factor, and brain natriuretic peptide as prognostic markers of survival in congestive heart failure
    Selvais, PL
    Robert, A
    Ahn, S
    Van Linden, F
    Ketelslegers, JM
    Pouleur, H
    Rousseau, MF
    JOURNAL OF CARDIAC FAILURE, 2000, 6 (03) : 201 - 207
12345